Bionovate Technologies Corp
BIIO
$0.0001
$0.000.00%
OTC PK
| 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 75.00% | -25.42% | 518.52% | 88.18% | -73.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 75.00% | -25.42% | 518.52% | 88.18% | -73.13% |
| Operating Income | -75.00% | 25.42% | -518.52% | -88.18% | 73.13% |
| Income Before Tax | 5.68% | 14.78% | -31.54% | 28.95% | 22.11% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 5.68% | 14.78% | -31.54% | 28.95% | 22.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.68% | 14.78% | -31.54% | 28.95% | 22.11% |
| EBIT | -75.00% | 25.42% | -518.52% | -88.18% | 73.13% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -600.00% | -175.00% | -16.67% | 99.79% | 99.79% |
| Normalized Basic EPS | -750.00% | -250.00% | 0.00% | 99.78% | 99.83% |
| EPS Diluted | -600.00% | -175.00% | -16.67% | 99.79% | 99.79% |
| Normalized Diluted EPS | -750.00% | -250.00% | 0.00% | 99.78% | 99.83% |
| Average Basic Shares Outstanding | -86.95% | -69.21% | 12.54% | 36,401.86% | 38,040.95% |
| Average Diluted Shares Outstanding | -86.95% | -69.21% | 12.54% | 36,401.86% | 38,040.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |